The investment seeks growth from capital appreciation... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category MidCapValue
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XPH | 37.66 | 1.01 | +2.76% |
SPDR® S&P Pharmaceuticals ETF | |||
EKG | 15.04 | 0.30 | +2.07% |
First Trust Nasdaq Lux Dgtl Hlth SoluETF | |||
GQRE | 54.80 | 1.06 | +1.97% |
FlexShares Glbl Quality Real Estate ETF | |||
LCF | 33.35 | 0.50 | +1.51% |
Touchstone US Large Cap Focused ETF | |||
BXMX | 12.55 | 0.17 | +1.37% |
NUVEEN S&P BUY-WRITE Income FUND |
A.I.dvisor indicates that over the last year, JMVZX has been closely correlated with VEVYX. These tickers have moved in lockstep 96% of the time. This A.I.-generated data suggests there is a high statistical probability that if JMVZX jumps, then VEVYX could also see price increases.
Ticker / NAME | Correlation To JMVZX | 1D Price Change % | ||
---|---|---|---|---|
JMVZX | 100% | N/A | ||
VEVYX - JMVZX | 96% Closely correlated | N/A | ||
MVCAX - JMVZX | 88% Closely correlated | N/A | ||
JVMCX - JMVZX | 88% Closely correlated | N/A | ||
JVMAX - JMVZX | 87% Closely correlated | N/A | ||
JVMRX - JMVZX | 83% Closely correlated | N/A | ||
More |